115 related articles for article (PubMed ID: 9151944)
1. Mutational analysis of the putative devazepide binding site of the CCK(A) receptor.
Smeets RL; IJzerman AP; Hermsen HP; Ophorst OJ; Van Emst-de Vries SE; De Pont JJ; Willems PH
Eur J Pharmacol; 1997 Apr; 325(1):93-9. PubMed ID: 9151944
[TBL] [Abstract][Full Text] [Related]
2. Full and partial agonist activity of C-terminal cholecystokinin peptides at the cloned human CCK-A receptor expressed in Chinese hamster ovary cells.
Dunlop J; Zhang Y; Evans N
Peptides; 1997; 18(6):865-8. PubMed ID: 9285936
[TBL] [Abstract][Full Text] [Related]
3. (3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist.
Semple G; Ryder H; Rooker DP; Batt AR; Kendrick DA; Szelke M; Ohta M; Satoh M; Nishida A; Akuzawa S; Miyata K
J Med Chem; 1997 Jan; 40(3):331-41. PubMed ID: 9022799
[TBL] [Abstract][Full Text] [Related]
4. Mutations within the cholecystokinin-B/gastrin receptor ligand 'pocket' interconvert the functions of nonpeptide agonists and antagonists.
Bläker M; Ren Y; Gordon MC; Hsu JE; Beinborn M; Kopin AS
Mol Pharmacol; 1998 Nov; 54(5):857-63. PubMed ID: 9804620
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant-like effects of CCK(B) receptor antagonists: involvement of the opioid system.
Hernando F; Fuentes JA; Fournié-Zaluski MC; Roques BP; Ruiz-Gayo M
Eur J Pharmacol; 1996 Dec; 318(2-3):221-9. PubMed ID: 9016909
[TBL] [Abstract][Full Text] [Related]
6. Are radioligand antagonist/agonist binding ratios in rat pancreas predictive of functional efficacy of cholecystokinin receptor agonists and antagonists?
Patel S; Chapman KL; Smith AJ; Bailey I; Freedman SB
Regul Pept; 1996 Aug; 65(1):29-35. PubMed ID: 8876033
[TBL] [Abstract][Full Text] [Related]
7. Direct demonstration of three different states of the pancreatic cholecystokinin receptor.
Talkad VD; Fortune KP; Pollo DA; Shah GN; Wank SA; Gardner JD
Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1868-72. PubMed ID: 8127897
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of the potential phosphorylation sites for protein kinase C on the CCK(A) receptor.
Smeets RL; Fouraux MA; Pouwels W; van Emst-de Vries SE; Ronken E; De Pont JJ; Willems PH
Br J Pharmacol; 1998 Jul; 124(5):935-45. PubMed ID: 9692779
[TBL] [Abstract][Full Text] [Related]
9. Characterization of [3H](+/-)L-364,718 binding to solubilized cholecystokinin (CCK) receptors of rat pancreas.
Chang RS; Lotti VJ; Chen TB
Biochem Pharmacol; 1987 May; 36(10):1709-14. PubMed ID: 3593394
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortex.
Harper EA; Griffin EP; Shankley NP; Black JW
Br J Pharmacol; 1999 Mar; 126(6):1496-503. PubMed ID: 10217545
[TBL] [Abstract][Full Text] [Related]
11. Cytosolic Ca2+ evaluation in rabbit parietal cells: a novel method to screen gastrin receptor antagonists.
Letari O; Mennuni L; Revel L; Colombo S; Makovec F
Eur J Pharmacol; 1996 Jun; 306(1-3):325-33. PubMed ID: 8813647
[TBL] [Abstract][Full Text] [Related]
12. The CCKB receptor antagonist, L-365,260, elicits antidepressant-type effects in the forced-swim test in mice.
Hernando F; Fuentes JA; Roques BP; Ruiz-Gayo M
Eur J Pharmacol; 1994 Aug; 261(3):257-63. PubMed ID: 7813546
[TBL] [Abstract][Full Text] [Related]
13. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion.
Blandizzi C; Lazzeri G; Colucci R; Carignani D; Tognetti M; Baschiera F; Del Tacca M
Eur J Pharmacol; 1999 May; 373(1):71-84. PubMed ID: 10408253
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini.
Talkad VD; Patto RJ; Metz DC; Turner RJ; Fortune KP; Bhat ST; Gardner JD
Biochim Biophys Acta; 1994 Oct; 1224(1):103-16. PubMed ID: 7524683
[TBL] [Abstract][Full Text] [Related]
15. Reduction of [125I]Bolton Hunter CCK8 and [3H]MK-329 (devazepide) binding to CCK receptors in the substantia nigra/VTA complex and its forebrain projection areas following MPTP-induced hemi-parkinsonism in the monkey.
Graham WC; Hill DR; Woodruff GN; Sambrook MA; Crossman AR
Neurosci Lett; 1991 Sep; 131(1):129-34. PubMed ID: 1791971
[TBL] [Abstract][Full Text] [Related]
16. Combined dose-ratio analysis of cholecystokinin receptor antagonists, devazepide, lorglumide and loxiglumide in the guinea-pig gall bladder.
Bishop LA; Gerskowitch VP; Hull RA; Shankley NP; Black JW
Br J Pharmacol; 1992 May; 106(1):61-6. PubMed ID: 1504732
[TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin increases intracellular Ca2+ concentration in the Human JURKAT T Lymphocyte cell line.
Lignon MF; Bernad N; Martinez J
Eur J Pharmacol; 1993 May; 245(3):241-6. PubMed ID: 8335062
[TBL] [Abstract][Full Text] [Related]
18. Cholecystokinin-8 (CCK-8) has no effect on heart rate in rats lacking CCK-A receptors.
Kurosawa M; Iijima S; Funakoshi A; Kawanami T; Miyasaka K; Bucinskaite V; Lundeberg T
Peptides; 2001 Aug; 22(8):1279-84. PubMed ID: 11457521
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning of an unusual bicistronic cholecystokinin receptor mRNA expressed in chicken brain: a structural and functional expression study.
Nilsson IB; Svensson SP; Monstein HJ
Regul Pept; 2003 Jun; 114(1):37-43. PubMed ID: 12763638
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological studies on CCKB receptors in guinea pig synaptoneurosomes.
Galas MC; Bernad N; Martinez J
Eur J Pharmacol; 1992 May; 226(1):35-41. PubMed ID: 1327841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]